NASDAQ:ADAP
$1.11
(
-5.13%
)
Friday, 26th May 2023
Adaptimmune Therapeutics plc Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $1.06 | $1.46 | Friday, 26th May 2023 ADAP stock ended at $1.11. This is 5.13% less than the trading day before Thursday, 25th May 2023. During the day the stock fluctuated 14.69% from a day low at $1.06 to a day high of $1.21. |
| 90 days | $1.01 | $1.85 | |
| 52 weeks | $1.01 | $2.64 |
Historical Adaptimmune Therapeutics plc prices
| Date | Open | High | Low | Close | Volume |
| 2023-05-26 | $1.09 | $1.21 | $1.06 | $1.11 | 1 433 249 |
| 2023-05-25 | $1.21 | $1.23 | $1.11 | $1.17 | 914 546 |
| 2023-05-24 | $1.23 | $1.24 | $1.15 | $1.20 | 902 138 |
| 2023-05-23 | $1.28 | $1.31 | $1.20 | $1.22 | 627 795 |
| 2023-05-22 | $1.32 | $1.33 | $1.27 | $1.28 | 410 420 |
| 2023-05-19 | $1.32 | $1.34 | $1.30 | $1.31 | 338 977 |
| 2023-05-18 | $1.33 | $1.38 | $1.28 | $1.31 | 450 837 |
| 2023-05-17 | $1.32 | $1.38 | $1.28 | $1.34 | 460 292 |
| 2023-05-16 | $1.36 | $1.37 | $1.31 | $1.31 | 264 511 |
| 2023-05-15 | $1.37 | $1.43 | $1.36 | $1.39 | 542 327 |
| 2023-05-12 | $1.42 | $1.42 | $1.35 | $1.37 | 418 063 |
| 2023-05-11 | $1.41 | $1.41 | $1.35 | $1.36 | 264 843 |
| 2023-05-10 | $1.40 | $1.44 | $1.38 | $1.40 | 257 362 |
| 2023-05-09 | $1.40 | $1.42 | $1.36 | $1.40 | 140 634 |
| 2023-05-08 | $1.42 | $1.45 | $1.37 | $1.40 | 234 698 |
| 2023-05-05 | $1.40 | $1.42 | $1.38 | $1.40 | 459 220 |
| 2023-05-04 | $1.42 | $1.42 | $1.36 | $1.39 | 198 326 |
| 2023-05-03 | $1.36 | $1.46 | $1.35 | $1.40 | 1 078 086 |
| 2023-05-02 | $1.40 | $1.43 | $1.36 | $1.37 | 340 047 |
| 2023-05-01 | $1.40 | $1.46 | $1.40 | $1.43 | 610 345 |
| 2023-04-28 | $1.39 | $1.43 | $1.33 | $1.42 | 401 305 |
| 2023-04-27 | $1.36 | $1.41 | $1.36 | $1.36 | 377 776 |
| 2023-04-26 | $1.32 | $1.39 | $1.32 | $1.36 | 345 206 |
| 2023-04-25 | $1.36 | $1.38 | $1.29 | $1.32 | 655 054 |
| 2023-04-24 | $1.35 | $1.44 | $1.33 | $1.38 | 814 235 |
| 2023-04-21 | $1.44 | $1.46 | $1.26 | $1.35 | 1 061 354 |
| 2023-04-20 | $1.50 | $1.50 | $1.41 | $1.41 | 852 573 |
| 2023-04-19 | $1.35 | $1.52 | $1.31 | $1.51 | 1 788 833 |
| 2023-04-18 | $1.40 | $1.40 | $1.32 | $1.35 | 1 306 342 |
| 2023-04-17 | $1.36 | $1.47 | $1.36 | $1.39 | 652 766 |
| 2023-04-14 | $1.27 | $1.40 | $1.27 | $1.36 | 1 080 552 |
| 2023-04-13 | $1.20 | $1.31 | $1.18 | $1.27 | 1 255 941 |
| 2023-04-12 | $1.22 | $1.22 | $1.17 | $1.19 | 658 025 |
| 2023-04-11 | $1.11 | $1.24 | $1.11 | $1.21 | 1 052 952 |
| 2023-04-10 | $1.10 | $1.14 | $1.08 | $1.13 | 693 279 |
| 2023-04-06 | $1.03 | $1.13 | $1.03 | $1.08 | 567 870 |
| 2023-04-05 | $1.03 | $1.05 | $1.01 | $1.05 | 370 125 |
| 2023-04-04 | $1.09 | $1.10 | $1.02 | $1.03 | 503 483 |
| 2023-04-03 | $1.04 | $1.11 | $1.04 | $1.06 | 519 668 |
| 2023-03-31 | $1.08 | $1.11 | $1.05 | $1.09 | 454 026 |
| 2023-03-30 | $1.05 | $1.10 | $1.04 | $1.06 | 252 716 |
| 2023-03-29 | $1.10 | $1.10 | $1.04 | $1.06 | 408 557 |
| 2023-03-28 | $1.10 | $1.12 | $1.05 | $1.06 | 521 325 |
| 2023-03-27 | $1.11 | $1.14 | $1.10 | $1.10 | 306 388 |
| 2023-03-24 | $1.11 | $1.12 | $1.06 | $1.10 | 562 726 |
| 2023-03-23 | $1.12 | $1.14 | $1.02 | $1.09 | 646 540 |
| 2023-03-22 | $1.19 | $1.20 | $1.10 | $1.11 | 525 855 |
| 2023-03-21 | $1.10 | $1.19 | $1.09 | $1.19 | 1 093 913 |
| 2023-03-20 | $1.12 | $1.15 | $1.07 | $1.09 | 1 377 615 |
| 2023-03-17 | $1.20 | $1.20 | $1.12 | $1.12 | 963 887 |
About Adaptimmune Therapeutics plc
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposa... ADAP Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
